Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where M Masoodi is active.

Publication


Featured researches published by M Masoodi.


International Immunopharmacology | 2010

The immunomodulatory properties of mesenchymal stem cells and their use for immunotherapy.

Martin J. Hoogduijn; Felix C. Popp; Richard Verbeek; M Masoodi; Anna Nicolaou; Carla C. Baan; Marc H. Dahlke

There is growing interest in the use of mesenchymal stem cells (MSC) for immune therapy. Clinical trials that use MSC for treatment of therapy resistant graft versus host disease, Crohns disease and organ transplantation have initiated. Nevertheless, the immunomodulatory effects of MSC are only partly understood. Clinical trials that are supported by basic research will lead to better understanding of the potential of MSC for immunomodulatory applications and to optimization of such therapies. In this manuscript we review some recent literature on the mechanisms of immunomodulation by MSC in vitro and animal models, present new data on the secretion of pro-inflammatory and anti-inflammatory cytokines, chemokines and prostaglandins by MSC under resting and inflammatory conditions and discuss the hopes and expectations of MSC-based immune therapy.


The FASEB Journal | 2009

The sunburn response in human skin is characterized by sequential eicosanoid profiles that may mediate its early and late phases

Lesley E. Rhodes; K Gledhill; M Masoodi; A Haylett; M Brownrigg; Anthony J. Thody; Desmond J. Tobin; Anna Nicolaou

Sunburn is a commonly occurring acute inflammatory process, with dermal vasodilatation and leukocyte infiltration as central features. Ultraviolet (UV) B‐induced hydrolysis of membrane phospholipids releases polyunsaturated fatty acids, and their subsequent metabolism by cyclooxygenases (COXs) and lipoxygenases (LOXs) may produce potent eicosanoid mediators modulating different stages of the inflammation. Our objective was to identify candidate eicosanoids formed during the sunburn reaction in relation to its clinical and histological course. We exposed skin of healthy humans (n=32) to UVB and, for 72 h, examined expression of proinflammatory and antiinflammatory eicosanoids using LC/ESI‐MS/MS, and examined immunohistochemical expression of COX‐2, 12‐LOX, 15‐LOX, and leukocyte markers, while quantifying clinical erythema. We show that vasodilatory prostaglandins (PGs) PGE2, PGF2a, and PGE3 accompany the erythema in the first 24–48 h, associated with increased COX‐2 expression at 24 h. Novel, potent leukocyte chemoattractants 11‐, 12‐, and 8‐monohydroxy‐eicosatetraenoic acid (HETE) are elevated from 4 to 72 h, in association with peak dermal neutrophil influx at 24 h, and increased dermal CD3+ lymphocytes and 12‐ and 15‐LOX expression from 24 to 72 h. Anti‐inflammatory metabolite 15‐HETE shows later expression, peaking at 72 h. Sunburn is characterized by overlapping sequential profiles of increases in COX products followed by LOX products that may regulate subsequent events and ultimately its resolution.—Rhodes, L. E., Gledhill, K., Masoodi, M., Haylett, A. K., Brownrigg, M., Thody, A. J., Tobin, D. J., Nicolaou, A. The sunburn response in human skin is characterized by sequential eicosanoid profiles that may mediate its early and late phases. FASEB J. 23, 3947–3956 (2009). www.fasebj.org


Pigment Cell & Melanoma Research | 2010

Prostaglandin-E2 is produced by adult human epidermal melanocytes in response to UVB in a melanogenesis-independent manner.

K Gledhill; Lesley E. Rhodes; M Brownrigg; A Haylett; M Masoodi; Anthony J. Thody; Anna Nicolaou; Desmond J. Tobin

Excessive ultraviolet radiation (UVR) exposure induces erythema, mediated in part by prostaglandin‐E2 (PGE2). While keratinocytes are a major PGE2 source, epidermal melanocytes (EM) also express PGE2‐production machinery. It is unclear whether EM‐produced PGE2 contributes to UVR‐induced skin inflammation, and whether this is correlated with melanogenesis. Epidermal melanocytes were cultured from skin phototype‐1 and ‐4 donors, followed by assessment of PGE2 production and melanogenesis. Epidermal melanocytes expressed cytoplasmic phospholipase‐A2, cyclooxygenase‐1, cytoplasmic prostaglandin‐E synthase and microsomal prostaglandin‐E synthase‐1, ‐2. Epidermal melanocytes produced PGE2 under basal conditions, which increased further after arachidonic acid stimulation. Epidermal melanocytes expressed cyclooxygenase‐2 (COX‐2) mRNA and a selective COX‐2 inhibitor (NS‐398) reduced PGE2 production. Ultraviolet B‐induced PGE2 production was positively correlated with skin phototype‐1, despite variability between individual EM donors. By contrast, there was no correlation between PGE2 production by EM and their melanogenic status. Thus, EM may contribute to UVR‐induced erythema, with role of donor skin phototype more important than their melanogenic status.


Photochemical and Photobiological Sciences | 2012

The eicosanoid response to high dose UVR exposure of individuals prone and resistant to sunburn

Anna Nicolaou; M Masoodi; K Gledhill; A Haylett; Anthony J. Thody; Desmond J. Tobin; Lesley E. Rhodes

High personal UVR doses can be gained during leisure activities, causing intense self-resolving inflammation (sunburn) of unprotected skin. UVR activates release of membrane fatty acids and upregulates their metabolism by cyclooxygenases (COX) and lipoxygenases (LOX) to different eicosanoids. While COX-derived prostaglandin (PG)E(2) is a potent mediator of sunburn vasodilatation, LOX-derived 15-hydroxyeicosatetraenoic acid (HETE) and its lipoxin metabolites may contribute to sunburn limitation. We explored the relationships between expression of these lipid mediators and the clinical and histological outcomes, comparing responses of individuals prone and more resistant to sunburn. An acute UVR exposure of 12 SED (standard erythema dose) was applied to buttock skin of 32 white Caucasians (n = 16 phototype I/II, n = 16 phototype III/IV), and over the subsequent 72 h assessments were made of skin erythema, immunohistochemical expression of leukocyte markers, COX-2, 12-LOX, 15-LOX and nitric oxide synthase (NOS), and eicosanoid levels by LC/ESI-MS/MS. Evidence of a significant inflammatory response was seen earlier in phototype I/II with regard to expression of erythema (4 h, p < 0.001), neutrophil infiltration (24 h, p = 0.01), epidermal COX-2 (24 h, p < 0.05) and 12-LOX (24 h, p < 0.01), and dermal eNOS (24 h, p < 0.05) proteins, although CD3+ lymphocyte infiltration showed an earlier increase in phototype III/IV (24 h, p < 0.05). Although erythema was equivalent at 72 h in both groups, phototype I/II showed higher PGE(2) accompanied by elevated 15-HETE, and a strong positive correlation was seen between these mediators (n = 18, r = 0.805, p = 0.0001). Hence anti-inflammatory eicosanoid 15-HETE may temper the pro-inflammatory milieu in sunburn, having greater influence in those prone to sunburn than those more resistant, given the same high UVR exposure conditions.


Experimental Dermatology | 2009

Prostaglandin D2 production in FM55 melanoma cells is regulated by α-melanocyte-stimulating hormone and is not related to melanin production

M Masoodi; Anna Nicolaou; K Gledhill; Lesley E. Rhodes; Desmond J. Tobin; Anthony J. Thody

Please cite this paper as: Prostaglandin D2 production in FM55 melanoma cells is regulated by α‐melanocyte‐stimulating hormone and is not related to melanin production. Experimental Dermatology 2010; 19: 751–753.


Methods of Molecular Biology | 2009

Lipidomic analysis of prostanoids by liquid chromatography-electrospray tandem mass spectrometry.

Anna Nicolaou; M Masoodi; Adnan A. Mir

Lipidomics aim to generate qualitative and quantitative information on different classes of lipids and their species, and when applied in conjunction with proteomic and genomic assays, facilitate the comprehensive study of lipid metabolism in cellular, organ, or body systems. Advances in mass spectrometry have underpinned the expansion of lipidomic methodologies. Prostanoids are potent autacoids present in a plethora of cellular systems, known best for their intimate role in inflammation. Electrospray ionisation (ESI) allows the efficient ionisation of prostanoids in aqueous systems. ESI can be readily coupled to liquid chromatography (LC) followed by tandem mass spectrometry (MS/MS)-based detection, thus allowing the development of a potent and selective LC/ESI-MS/MS quantitative assays. The protocol we describe in this chapter outlines the steps we follow to (a) extract prostanoids from solid or liquid samples, (b) semi-purify the metabolites using solid phase extraction (c) set-up the HPLC separation using reverse phase chromatography and (d) set-up the MS/MS assay using a triple quadrupole mass spectrometer. The experimental details and notes presented here are based on the detailed protocols followed in our group.


Rapid Communications in Mass Spectrometry | 2006

Lipidomic analysis of twenty-seven prostanoids and isoprostanes by liquid chromatography/electrospray tandem mass spectrometry

M Masoodi; Anna Nicolaou


Rapid Communications in Mass Spectrometry | 2008

Simultaneous lipidomic analysis of three families of bioactive lipid mediators leukotrienes, resolvins, protectins and related hydroxy-fatty acids by liquid chromatography/electrospray ionisation tandem mass spectrometry.

M Masoodi; Adnan A. Mir; Nicos A. Petasis; Charles N. Serhan; Anna Nicolaou


The FASEB Journal | 2013

The low level of EPA in brain phospholipids is maintained by multiple compensatory mechanisms

Chuck T. Chen; Anthony F. Domenichiello; Marc-Olivier Trépanier; Zhen Liu; M Masoodi; Richard P. Bazinet


In: British Society for Investigative Dermatology; 12 Apr 2010-14 Apr 2010; Edinburgh, UK. British Journal of Dermatology; 2010. p. 944-944. | 2010

Adult human epidermal melanocytes produce the pro-inflammatory eicosanoid prostaglandin E2 in response to UVB.

K Gledhill; Lesley E. Rhodes; M Brownrigg; A Haylett; M Masoodi; Anthony J. Thody; Anna Nicolaou; Desmond J. Tobin

Collaboration


Dive into the M Masoodi's collaboration.

Top Co-Authors

Avatar

Anna Nicolaou

University of Manchester

View shared research outputs
Top Co-Authors

Avatar

Lesley E. Rhodes

Manchester Academic Health Science Centre

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

K Gledhill

University of Bradford

View shared research outputs
Top Co-Authors

Avatar

A Haylett

Manchester Academic Health Science Centre

View shared research outputs
Top Co-Authors

Avatar

M Brownrigg

Manchester Academic Health Science Centre

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Charles N. Serhan

Brigham and Women's Hospital

View shared research outputs
Top Co-Authors

Avatar

Nicos A. Petasis

University of Southern California

View shared research outputs
Researchain Logo
Decentralizing Knowledge